. , Les cibles hémidesmosomales des auto-anticorps de la PB

. , Cibles épitopiques au sein de BP180, l'autoantigène majeur de la PB et notion de diffusion du répertoire auto-immun

. , Mécanismes physiopahologiques aboutissant à l'apparition

E. .. Traitement,

. Rituximab and .. .. Pemphigoïde-bulleuse,

A. , Diffusion épitopique au cours de l'évolution de la pemphigoïde bulleuse

.. .. Hémophilie,

A. .. Généralités,

B. .. Traitement, étiologique : éradiquer l'inhibiteur du FVIII

A. .. ,

C. .. Et-perspectives,

I. Atteinte-oesophagienne-dans-la-pemphigoïde-bulleuse and .. .. ,

A. Atteinte-oesophagienne-des and D. .. ,

B. , Revue de la littérature : atteinte oesophagienne de la pemphigoïde bulleuse, p.43

C. , Rôle de la diffusion du répertoire auto-immun ?

I. I. Hémophilie and .. .. ,

A. Susceptibilité-génétique and ?. .. ,

B. , Rôle de la diffusion épitopique ?

C. .. ,

T. .. ,

B. .. ,

R. Kruse-jarres, C. L. Kempton, F. Baudo, P. W. Collins, P. Knoebl et al., Acquired hemophilia A: Updated review of evidence and treatment guidance, Am J Hematol, vol.92, issue.7, pp.695-705, 2017.

S. Shetty, M. Bhave, and K. Ghosh, Acquired hemophilia A: Diagnosis, aetiology, clinical spectrum and treatment options, Autoimmun Rev, vol.10, issue.6, pp.311-317, 2011.

R. Prud'homme, S. Assikar, D. Audevard, and C. Bédane, Dermatoses bulleuses auto-immunes et hémophilie A acquise : 2 pathologies éloignées mais qui semblent se rapprocher par l'immunologie, Ann Dermatol Venereol, vol.143, issue.12, p.223, 2016.

A. Hokama, Esophagitis dissecans superficialis and autoimmune bullous dermatoses: A review, World Journal of Gastrointestinal Endoscopy, vol.2, issue.7, p.252, 2010.

P. Bernard and F. Antonicelli, Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment, Am J Clin Dermat, vol.18, issue.4, pp.513-541, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01825913

T. Y. Eng, W. J. Hogan, and R. E. Jordon, Oesophageal involvement in bullous pemphigoid. A possible cause of gastrointestinal haemorrhage, Br J Dermatol, vol.99, issue.2, pp.207-217, 1978.

P. Sharon, M. L. Greene, and D. Rachmilewitz, Esophageal involvement in bullous pemphigoid

, Gastrointest Endosc, vol.24, issue.3, pp.122-125, 1978.

B. Labeille, P. Dupuy, R. Delcenserie, J. L. Dupas, M. F. Gontier et al., Bullous pemphigoid with esophageal bullosis, Ann Dermatol Venereol, vol.112, issue.3, pp.261-264, 1985.

R. Nagashima, K. Tsuge, M. Harada, Y. Katagiri, H. Shinzawa et al., Endoscopic hemostasis of hemorrhage from esophageal bullous pemphigoid, Gastrointest Endosc, vol.52, issue.3, pp.433-437, 2000.

H. Seddik and E. A. Elfeydi, Pemphigoïde bulleuse avec localisation oesophagienne

, Acta Endosc, vol.33, issue.2, pp.263-267, 2003.

V. H. Chong, C. C. Lim, and C. Vu, A rare cause of acute upper gastrointestinal bleeding, Surg Laparosc Endosc Percutan Tech, vol.16, issue.2, pp.91-94, 2006.

N. Maharshak, M. Sagi, E. Santos, E. Sprecher, and I. Goldberg, Oesophageal involvement in bullous pemphigoid, Clin Exp Dermatol, vol.38, issue.3, pp.274-279, 2013.
DOI : 10.1111/j.1365-2230.2012.04408.x

K. Mönkemüller and C. M. Wilcox, Bullous and Exfoliative Esophagitis, Vid J Encycl GI Endosc, vol.1, issue.1, pp.8-9, 2013.

B. M. Tijjani, I. Masoodi, and S. N. Hassan, Esophagitis dissecans superficialis presenting with massive haematemesis in a patient with bullous pemphigoid, Niger J Med, vol.22, issue.4, pp.354-360, 2013.

H. Meyiz and I. Mellouki, Oesophagite disséquante: une cause rare de dysphagie, Pan Afr Med J, vol.6, p.164, 2014.
DOI : 10.11604/pamj.2014.17.164.4039

URL : https://doi.org/10.11604/pamj.2014.17.164.4039

S. L. Shah, Esophagitis Dissecans Superficialis with Concomitant Bullous Pemphigoid: A Case Report, J Dermatol Res Ther, vol.2, p.29, 2016.

R. Gaspar, P. Moutinho-ribeiro, and G. Macedo, Bullous pemphigoid: extensive esophageal involvement, Gastrointest Endosc, vol.86, issue.2, pp.400-402, 2017.
DOI : 10.1016/j.gie.2017.02.015

K. Mönkemüller, H. Neumann, and L. C. Fry, Esophageal blebs and blisters, Gastroenterology, vol.138, issue.2, pp.3-4, 2010.

L. S. Chan, C. J. Vanderlugt, T. Hashimoto, T. Nishikawa, J. J. Zone et al., Epitope Spreading: Lessons From Autoimmune Skin Diseases, J Invest Dermatol, vol.110, issue.2, pp.103-112, 1998.
DOI : 10.1046/j.1523-1747.1998.00107.x

URL : https://doi.org/10.1046/j.1523-1747.1998.00107.x

D. Zenzo, G. Thoma-uszynski, S. Calabresi, V. Fontao, L. Hofmann et al., Demonstration of Epitope-Spreading Phenomena in Bullous Pemphigoid: Results of a Prospective Multicenter Study, J Invest Dermatol, vol.131, issue.11, pp.2271-80, 2011.

M. Sárdy, A. Borovaya, O. N. Horváth, C. Folwaczny, W. Schmitt et al., Successful rituximab treatment of juvenile bullous pemphigoid with esophageal scarring due to epitope spreading, J Dtsch Dermatol Ges, vol.14, issue.6, pp.618-639, 2016.

A. Recke, C. Rose, E. Schmidt, E. Bröcker, D. Zillikens et al., Transition from pemphigus foliaceus to bullous pemphigoid: Intermolecular B-cell epitope spreading without IgG subclass shifting, J Am Acad Dermatol, vol.61, issue.2, pp.333-339, 2009.
DOI : 10.1016/j.jaad.2008.10.061

J. D. Peterson, A. J. Chang, and L. S. Chan, Clinical evidence of an intermolecular epitope spreading in a patient with pemphigus foliaceus converting into bullous pemphigoid, Arch Dermatol, vol.143, issue.2, pp.272-276, 2007.

J. Y. Maeda, A. Moura, C. W. Maruta, C. G. Santi, P. S. Prisayanh et al., Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid, Clin Exp Dermatol, vol.31, issue.5, pp.653-658, 2006.

N. Sami and A. R. Ahmed, Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature, Dermatology, vol.202, issue.4, pp.293-301, 2001.
DOI : 10.1159/000051661

J. A. Fairley, D. T. Woodley, M. Chen, G. J. Giudice, and M. Lin, A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading, J Am Acad Dermatol, vol.51, issue.1, pp.118-140, 2004.
DOI : 10.1016/j.jaad.2003.12.033

M. Kasperkiewicz, U. Hoppe, D. Zillikens, and E. Schmidt, Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid: Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid, Clin Exp Dermatol, vol.35, issue.6, pp.614-621, 2009.

A. Czernik and M. Wieczorek, Paraneoplastic pemphigus: a short review, Clin Cosmet Investig Dermatol, vol.9, pp.291-296, 2016.
DOI : 10.2147/ccid.s100802

URL : https://www.dovepress.com/getfile.php?fileID=32606

P. Knoebl, P. Marco, F. Baudo, P. Collins, A. Huth-kühne et al., Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2): Demographics of acquired hemophilia A, J Thromb Haemost, vol.10, issue.4, pp.622-653, 2012.

Q. Binet, C. Lambert, L. Sacr, S. Eeckhoudt, and C. Hermans, Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature, Case Rep Hematol, pp.1-7, 2017.

E. Alpsoy, A. Akman-karakas, and S. Uzun, Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid, Arch Dermatol Res, vol.307, issue.4, pp.291-299, 2015.

P. Joly, S. Baricault, A. Sparsa, P. Bernard, C. Bédane et al., Incidence and mortality of bullous pemphigoid in France, J Invest Dermatol, vol.132, issue.8, pp.1998-2004, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00729013

P. Bernard, L. Vaillant, B. Labeille, C. Bedane, B. Arbeille et al., Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group, Arch Dermatol, vol.131, issue.1, pp.48-52, 1995.

P. Bernard and F. Antonicelli, Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment, Am J Clin Dermatol, vol.18, issue.4, pp.513-541, 2017.
DOI : 10.1007/s40257-017-0264-2

URL : https://hal.archives-ouvertes.fr/hal-01825913

L. Vaillant, P. Bernard, P. Joly, C. Prost, B. Labeille et al., Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group, Arch Dermatol, vol.134, issue.9, pp.1075-80, 1998.

A. Roussel, J. Benichou, Z. A. Randriamanantany, D. Gilbert, K. Drenovska et al.,

, Enzyme-Linked Immunosorbent Assay for the Combination of Bullous Pemphigoid Antigens 1 and 2 in the Diagnosis of Bullous Pemphigoid, Arch Dermatol, vol.147, issue.3, p.293, 2011.

L. Fania, G. Caldarola, R. Müller, O. Brandt, R. Pellicano et al., IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses, Clin Immunol, vol.143, issue.3, pp.236-281, 2012.

S. M. Langan, R. W. Groves, and J. West, The Relationship between Neurological Disease and Bullous Pemphigoid: A Population-Based Case-Control Study, J Invest Dermatol, vol.131, issue.3, pp.631-637, 2011.

K. Taghipour, C. Chi, A. Vincent, R. W. Groves, V. Venning et al., The Association of Bullous Pemphigoid With Cerebrovascular Disease and Dementia: A CaseControl Study, Arch Dermatol, issue.11, p.146, 2010.

F. Fichel, C. Barbe, P. Joly, C. Bedane, P. Vabres et al., Clinical and Immunologic Factors Associated With Bullous Pemphigoid Relapse During the First Year of Treatment: A Multicenter, Prospective Study, JAMA Dermatol, vol.150, issue.1, p.25, 2014.

K. Messingham, S. Aust, J. Helfenberger, K. L. Parker, S. Schultz et al., Autoantibodies to Collagen XVII Are Present in Parkinson's Disease and Localize to TyrosineHydroxylase Positive Neurons, J Invest Dermatol, vol.136, issue.3, pp.721-724, 2016.

K. T. Amber, J. Zikry, and M. Hertl, A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA-DQB1*03:01 , a potential link between immune privileged antigen exposure and epitope spreading?, HLA, vol.89, issue.3, pp.127-161, 2017.

S. Bastuji-garin, P. Joly, P. Lemordant, A. Sparsa, C. Bedane et al., Risk factors for bullous pemphigoid in the elderly: a prospective case-control study, J Invest Dermatol, vol.131, issue.3, pp.637-680, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00575257

S. Bastuji-garin, P. Joly, C. Picard-dahan, P. Bernard, L. Vaillant et al., Drugs associated with bullous pemphigoid. A case-control study, Arch Dermatol, vol.132, issue.3, pp.272-278, 1996.

A. Lloyd-lavery, C. Chi, F. Wojnarowska, and K. Taghipour, The associations between bullous pemphigoid and drug use: a UK case-control study, JAMA Dermatol, vol.149, issue.1, pp.58-62, 2013.

J. Béné, G. Moulis, I. Bennani, M. Auffret, P. Coupe et al., Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database, Br J Dermatol, vol.175, issue.2, pp.296-301, 2016.

W. Damsky, L. Kole, and M. M. Tomayko, Development of bullous pemphigoid during nivolumab therapy, JAAD Case Rep, vol.2, issue.6, pp.442-446, 2016.

O. Rofe, G. Bar-sela, Z. Keidar, T. Sezin, C. D. Sadik et al., Severe bullous pemphigoid associated with pembrolizumab therapy for metastatic melanoma with complete regression, Clin Exp Dermatol, vol.42, issue.3, pp.309-321, 2017.

L. Sowerby, A. K. Dewan, S. Granter, L. Gandhi, and N. R. Leboeuf, Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid, JAMA Dermatol, vol.153, issue.6, p.603, 2017.

S. D?nescu, R. Chiorean, V. Macovei, C. Sitaru, and A. Baican, Role of physical factors in the pathogenesis of bullous pemphigoid: Case report series and a comprehensive review of the published work, J Dermatol, vol.43, issue.2, pp.134-174, 2016.

G. Taylor, V. Venning, F. Wojnarowska, and K. Welch, Bullous pemphigoid and autoimmunity

, J Am Acad Dermatol, vol.29, issue.2, pp.181-185, 1993.

Y. J. Chen, C. Y. Wu, M. W. Lin, T. J. Chen, K. K. Liao et al., Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study: Comorbidity profiles among patients with BP, British Journal of Dermatology, vol.165, issue.3, pp.593-602, 2011.

W. Nishie, Update on the pathogenesis of bullous pemphigoid: An autoantibodymediated blistering disease targeting collagen XVII, J Dermatol Sci, vol.73, issue.3, pp.179-86, 2014.

E. Fuchs and S. Raghavan, Getting under the skin of epidermal morphogenis, Nat Rev Genet, vol.3, issue.3, pp.199-209, 2002.

S. Thoma-uszynski, W. Uter, S. Schwietzke, G. Schuler, L. Borradori et al., Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230, J Immunol Baltim Md, vol.176, issue.3, pp.2015-2038, 2006.

J. M. Moilanen, N. Kokkonen, S. Löffek, J. P. Väyrynen, E. Syväniemi et al.,

, Collagen XVII expression correlates with the invasion and metastasis of colorectal cancer, Hum Pathol, vol.46, issue.3, pp.434-476, 2015.

M. Furue and T. Kadono, Bullous pemphigoid: What's ahead?, J Dermatol, vol.43, issue.3, pp.237-277, 2016.

W. Nishie, D. Sawamura, M. Goto, K. Ito, A. Shibaki et al., Humanization of autoantigen, Nat Med, vol.13, issue.3, pp.378-83, 2007.

T. Hurskainen, N. Kokkonen, R. Sormunen, J. Jackow, S. Löffek et al., Deletion of the Major Bullous Pemphigoid Epitope Region of Collagen XVII Induces Blistering, Autoimmunization, and Itching in Mice, J Invest Dermatol, vol.135, issue.5, pp.1303-1313, 2015.

D. Zenzo, G. Thoma-uszynski, S. Fontao, L. Calabresi, V. Hofmann et al.,

, Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid, Clin Immunol, vol.128, issue.3, pp.415-441, 2008.

M. Kalowska, O. Ciepiela, C. Kowalewski, U. Demkow, R. A. Schwartz et al., Enzymelinked Immunoassay Index for Anti-NC16a IgG and IgE Auto-antibodies Correlates with Severity and Activity of Bullous Pemphigoid, Acta Derm Venereol, vol.96, issue.2, pp.191-197, 2016.

X. Zhou, B. Liu, Q. Xu, Y. Yang, C. He et al., Serum levels of immunoglobulins G1 and G4 targeting the non-collagenous 16A domain of BP180 reflect bullous pemphigoid activity and predict bad prognosis, J Dermatol, vol.43, issue.2, pp.141-149, 2016.

D. Zenzo, G. Calabresi, V. Olasz, E. B. Zambruno, G. Yancey et al., Sequential Intramolecular Epitope Spreading of Humoral Responses to Human BPAG2 in a Transgenic Model, J Invest Dermatol, vol.130, issue.4, pp.1040-1047, 2010.

D. Zenzo, G. Thoma-uszynski, S. Calabresi, V. Fontao, L. Hofmann et al., Demonstration of Epitope-Spreading Phenomena in Bullous Pemphigoid: Results of a Prospective Multicenter Study, J Invest Dermatol, vol.131, issue.11, pp.2271-80, 2011.

E. B. Olasz, J. Roh, C. L. Yee, K. Arita, M. Akiyama et al., Human Bullous Pemphigoid Antigen 2 Transgenic Skin Elicits Specific IgG in Wild-Type Mice, J Invest Dermatol, vol.127, issue.12, pp.2807-2824, 2007.

J. C. Delgado, D. Turbay, E. J. Yunis, J. J. Yunis, E. D. Morton et al., A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid, Proc Natl Acad Sci, vol.93, issue.16, pp.8569-71, 1996.

L. R. Zakka, P. Reche, and A. R. Ahmed, Role of MHC Class II Genes in the pathogenesis of pemphigoid, Autoimmun Rev, vol.11, issue.1, pp.40-47, 2011.

G. Wang, H. Ujiie, A. Shibaki, W. Nishie, Y. Tateishi et al., Blockade of Autoantibody-Initiated Tissue Damage by Using Recombinant Fab Antibody Fragments against Pathogenic Autoantigen, Am J Pathol, vol.176, issue.2, pp.914-939, 2010.
DOI : 10.2353/ajpath.2010.090744

URL : http://europepmc.org/articles/pmc2808096?pdf=render

Q. Li, H. Ujiie, A. Shibaki, G. Wang, R. Moriuchi et al., Human IgG1 Monoclonal Antibody against Human Collagen 17 Noncollagenous 16A Domain Induces Blisters via Complement Activation in Experimental Bullous Pemphigoid Model, J Immunol, vol.185, issue.12, pp.7746-55, 2010.
DOI : 10.4049/jimmunol.1000667

URL : http://www.jimmunol.org/content/185/12/7746.full.pdf

Z. Liu, G. J. Giudice, S. J. Swartz, J. A. Fairley, G. O. Till et al., The role of complement in experimental bullous pemphigoid, J Clin Invest, vol.95, issue.4, pp.1539-1583, 1995.

S. Shiraishi, T. Iio, Y. Shirakata, K. Sayama, H. Nishimukai et al., Bullous pemphigoid in a patient with a C4 deficiency, Br J Dermatol, vol.124, issue.3, pp.296-304, 1991.

H. Iwata, N. Kamio, Y. Aoyama, Y. Yamamoto, Y. Hirako et al., IgG from Patients with Bullous Pemphigoid Depletes Cultured Keratinocytes of the 180-kDa Bullous Pemphigoid Antigen (Type XVII Collagen) and Weakens Cell Attachment, J Invest Dermatol, vol.129, issue.4, pp.919-945, 2009.
DOI : 10.1038/jid.2008.305

URL : https://doi.org/10.1038/jid.2008.305

L. Lin, T. Betsuyaku, L. Heimbach, N. Li, D. Rubenstein et al., Neutrophil elastase cleaves the murine hemidesmosomal protein BP180/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid, Matrix Biol, vol.31, issue.1, pp.38-44, 2012.
DOI : 10.1016/j.matbio.2011.09.003

URL : http://europepmc.org/articles/pmc3261345?pdf=render

K. Messingham, H. M. Holahan, and J. A. Fairley, Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid, Immunol Res, vol.59, issue.1-3, pp.273-281, 2014.

K. Messingham, M. H. Noe, M. A. Chapman, G. J. Giudice, and J. A. Fairley, A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid, J Immunol Methods, vol.346, issue.1-2, pp.18-25, 2009.

O. G. Dimson, G. J. Giudice, C. L. Fu, F. Van-den-bergh, S. J. Warren et al., Identification of a Potential Effector Function for IgE Autoantibodies in the Organ-Specific Autoimmune Disease Bullous Pemphigoid, J Invest Dermatol, vol.120, issue.5, pp.784-792, 2003.

N. Van-beek, N. Lüttmann, F. Huebner, A. Recke, K. I. Schulze et al., Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity, JAMA Dermatol, vol.153, issue.1, p.30, 2017.

J. A. Fairley, C. T. Burnett, C. Fu, D. L. Larson, M. G. Fleming et al., A Pathogenic Role for IgE in Autoimmunity: Bullous Pemphigoid IgE Reproduces the Early Phase of Lesion Development in Human Skin Grafted to nu/nu Mice, J Invest Dermatol, vol.127, issue.11, pp.2605-2616, 2007.

J. A. Fairley, C. L. Baum, D. S. Brandt, and K. Messingham, Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab, J Allergy Clin Immunol, vol.123, issue.3, pp.704-709, 2009.

C. Dufour, A. L. Souillet, C. Chaneliere, F. Jouen, C. Bodemer et al., Successful management of severe infant bullous pemphigoid with omalizumab: Correspondence, Br J Dermatol, vol.166, issue.5, pp.1140-1142, 2012.
DOI : 10.1111/j.1365-2133.2011.10748.x

G. Balakirski, A. Alkhateeb, H. F. Merk, M. Leverkus, and M. Megahed, Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature, J Eur Acad Dermatol Venereol, vol.30, issue.10, pp.1778-82, 2016.

P. Joly, S. Oro, P. Squarcioni, C. Bernard, P. Bedane et al., Protocole National de Diagnostic et de Soins (PNDS) Pemphigoïde bulleuse (PB). Centres de référence des maladies bulleuses auto-immunes, 2016.

P. Joly, J. Roujeau, J. Benichou, C. Picard, B. Dreno et al., A comparison of oral and topical corticosteroids in patients with bullous pemphigoid, N Engl J Med, vol.346, issue.5, pp.321-328, 2002.

P. Joly, J. Roujeau, J. Benichou, E. Delaporte, D. 'incan et al., A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study, J Invest Dermatol, vol.129, issue.7, pp.1681-1688, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00396990

H. M. Gürcan, R. Ahmed, and A. , Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid, Br J Dermatol, vol.161, issue.4, pp.723-754, 2009.

P. Joly, M. Maho-vaillant, C. Prost-squarcioni, V. Hebert, E. Houivet et al., Firstline rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial, Lancet, vol.389, pp.2031-2071, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01540071

M. Kasperkiewicz, I. Shimanovich, R. J. Ludwig, C. Rose, D. Zillikens et al., Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients, J Am Acad Dermatol, vol.65, issue.3, pp.552-560, 2011.
DOI : 10.1016/j.jaad.2010.07.032

L. Roux-villet and C. , Rituximab for Patients With Refractory Mucous Membrane Pemphigoid, Arch Dermatol, vol.147, issue.7, p.843, 2011.

A. Maley, M. Warren, I. Haberman, R. Swerlick, B. Kharod-dholakia et al., Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP), J Am Acad Dermatol, vol.74, issue.5, pp.835-875, 2016.

C. You, N. Lamba, A. F. Lasave, L. Ma, M. H. Diaz et al., Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study, Graefes Arch Clin Exp Ophthalmol, vol.255, issue.6, pp.1221-1229, 2017.

S. Shetty and A. R. Ahmed, Treatment of bullous pemphigoid with rituximab: critical analysis of the current literature, J Drugs Dermatol, vol.12, issue.6, pp.672-679, 2013.

Y. T. Cho, C. Y. Chu, and L. F. Wang, First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid, Br J Dermatol, vol.173, issue.1, pp.302-306, 2015.
DOI : 10.1111/bjd.13633

A. R. Ahmed, S. Shetty, S. Kaveri, and Z. S. Spigelman, Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up, J Am Acad Dermatol, vol.74, issue.4, pp.700-708, 2016.

L. S. Chan, C. J. Vanderlugt, T. Hashimoto, T. Nishikawa, J. J. Zone et al., Epitope Spreading: Lessons From Autoimmune Skin Diseases, J Invest Dermatol, vol.110, issue.2, pp.103-112, 1998.
DOI : 10.1046/j.1523-1747.1998.00107.x

URL : https://doi.org/10.1046/j.1523-1747.1998.00107.x

M. Sárdy, A. Borovaya, O. N. Horváth, C. Folwaczny, W. Schmitt et al., Successful rituximab treatment of juvenile bullous pemphigoid with esophageal scarring due to epitope spreading, J Dtsch Dermatol Ges J Ger Soc Dermatol, vol.14, issue.6, pp.618-639, 2016.

A. Recke, C. Rose, E. Schmidt, E. Bröcker, D. Zillikens et al., Transition from pemphigus foliaceus to bullous pemphigoid: Intermolecular B-cell epitope spreading without IgG subclass shifting, J Am Acad Dermatol, vol.61, issue.2, pp.333-339, 2009.
DOI : 10.1016/j.jaad.2008.10.061

J. D. Peterson, A. J. Chang, and L. S. Chan, Clinical evidence of an intermolecular epitope spreading in a patient with pemphigus foliaceus converting into bullous pemphigoid, Arch Dermatol, vol.143, issue.2, pp.272-276, 2007.

J. Y. Maeda, A. Moura, C. W. Maruta, C. G. Santi, P. S. Prisayanh et al., Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid, Clin Exp Dermatol, vol.31, issue.5, pp.653-658, 2006.

N. Sami and A. R. Ahmed, Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature, Dermatol Basel Switz, vol.202, issue.4, pp.293-301, 2001.
DOI : 10.1159/000051661

J. A. Fairley, D. T. Woodley, M. Chen, G. J. Giudice, and M. Lin, A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading, J Am Acad Dermatol, vol.51, issue.1, pp.118-140, 2004.
DOI : 10.1016/j.jaad.2003.12.033

M. Kasperkiewicz, U. Hoppe, D. Zillikens, and E. Schmidt, Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid: Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid, Clin Exp Dermatol, vol.35, issue.6, pp.614-621, 2009.

R. Kruse-jarres, C. L. Kempton, F. Baudo, P. W. Collins, P. Knoebl et al., Acquired hemophilia A: Updated review of evidence and treatment guidance, Am J Hematol, vol.92, issue.7, pp.695-705, 2017.
DOI : 10.1002/ajh.24777

P. Knoebl, P. Marco, F. Baudo, P. Collins, A. Huth-kühne et al., Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2): Demographics of acquired hemophilia A, J Thromb Haemost, vol.10, issue.4, pp.622-653, 2012.

F. Baudo, P. Collins, A. Huth-kuhne, H. Levesque, P. Marco et al., Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry, Blood, vol.120, issue.1, pp.39-46, 2012.

S. Werwitzke, U. Geisen, U. Nowak-göttl, H. Eichler, B. Stephan et al., Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study, J Thromb Haemost, vol.14, issue.5, pp.940-947, 2016.

R. Kruse-jarres, J. St-louis, A. Greist, A. Shapiro, H. Smith et al., Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A, Haemophilia, vol.21, issue.2, pp.162-70, 2015.

P. Collins, F. Baudo, P. Knoebl, H. Levesque, L. Nemes et al., Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2), Blood, vol.120, issue.1, pp.47-55, 2012.
DOI : 10.1182/blood-2012-02-409185

URL : http://www.bloodjournal.org/content/bloodjournal/120/1/47.full.pdf

Y. Zeng, R. Zhou, X. Duan, and D. Long, Rituximab for eradicating inhibitors in people with acquired haemophilia, Cochrane Database Syst REV. 2016, vol.8, p.11907

A. Hokama, Esophagitis dissecans superficialis and autoimmune bullous dermatoses: A review, World J Gastrointest Endosc, vol.2, issue.7, p.252, 2010.

R. Nakamura, T. Omori, K. Suda, N. Wada, H. Kawakubo et al., Endoscopic findings of laryngopharyngeal and esophageal involvement in autoimmune bullous disease, Available from, 2017.

C. Bédane, D. Hantz, and V. , Mucous membrane pemphigoid: a review, Ann Dermatol Venereol, vol.138, issue.3, pp.201-209, 2011.

O. Zehou, J. Raynaud, L. Roux-villet, C. Alexandre, M. Airinei et al., Oesophageal involvement in 26 consecutive patients with mucous membrane pemphigoid, Br J Dermato, 2016.

N. Takayama, S. Nakazono, J. Kumagai, T. Kawamura, F. Suzuki et al., Case of subepidermal bullous disease with diffuse esophageal involvement presenting with immunoglobulin G autoantibodies to both the BP180 NC16a and C-terminal domains, and immunoglobulin A autoantibodies to the BP180 NC16a domain, J Dermatol, vol.41, issue.7, pp.665-672, 2014.

P. Foroozan, T. Enta, D. H. Winship, and J. S. Trier, Loss and regeneration of the esophageal mucosa in pemphigoid, Gastroenterology, vol.52, issue.3, pp.548-58, 1967.

T. Y. Eng, W. J. Hogan, and R. E. Jordon, Oesophageal involvement in bullous pemphigoid. A possible cause of gastrointestinal haemorrhage, Br J Dermatol, vol.99, issue.2, pp.207-217, 1978.

P. Sharon, M. L. Greene, and D. Rachmilewitz, Esophageal involvement in bullous pemphigoid

, Gastrointest Endosc, vol.24, issue.3, pp.122-125, 1978.

R. Nagashima, K. Tsuge, M. Harada, Y. Katagiri, H. Shinzawa et al., Endoscopic hemostasis of hemorrhage from esophageal bullous pemphigoid, Gastrointest Endosc, vol.52, issue.3, pp.433-437, 2000.

H. Seddik and E. A. Elfeydi, Pemphigoïde bulleuse avec localisation oesophagienne

, Acta Endosc, vol.33, issue.2, pp.263-267, 2003.

V. H. Chong, C. C. Lim, and C. Vu, A rare cause of acute upper gastrointestinal bleeding, Surg Laparosc Endosc Percutan Tech, vol.16, issue.2, pp.91-94, 2006.

W. Wu and C. Chu, Bullous Pemphigoid with Esophageal Involvement Presenting as Exfoliative Esophagitis and Acute Upper Gastrointestinal Bleeding: Reports of Two Cases and Review of the Literature. Dermatol Sinica, vol.26, pp.171-179, 2008.

K. Mönkemüller, H. Neumann, and L. C. Fry, Esophageal blebs and blisters, Gastroenterology, vol.138, issue.2, pp.3-4, 2010.

N. Maharshak, M. Sagi, E. Santos, E. Sprecher, and I. Goldberg, Oesophageal involvement in bullous pemphigoid, Clin Exp Dermatol, vol.38, issue.3, pp.274-279, 2013.

B. M. Tijjani, I. Masoodi, and S. N. Hassan, Esophagitis dissecans superficialis presenting with massive haematemesis in a patient with bullous pemphigoid, Niger J Med, vol.22, issue.4, pp.354-360, 2013.

H. Meyiz and I. Mellouki, Oesophagite disséquante: une cause rare de dysphagie, Pan Afr Med J, vol.6, p.164, 2014.

S. L. Shah, Esophagitis Dissecans Superficialis with Concomitant Bullous Pemphigoid: A Case Report, J Dermatol Res Ther, vol.2, issue.4, 2016.

R. Gaspar, P. Moutinho-ribeiro, and G. Macedo, Bullous pemphigoid: extensive esophageal involvement, Gastrointest Endosc, vol.86, issue.2, pp.400-402, 2017.
DOI : 10.1016/j.gie.2017.02.015

A. Czernik and M. Wieczorek, Paraneoplastic pemphigus: a short review, Clin Cosmet Investig Dermatol, vol.9, pp.291-296, 2016.
DOI : 10.2147/ccid.s100802

URL : https://www.dovepress.com/getfile.php?fileID=32606

C. Biron, L. Durand, T. Lemkecher, J. Dauverchain, L. Meunier et al., Simultaneous occurrence of lupus anticoagulant, factor VIII inhibitor and localized pemphigoid, Am J Hematol, vol.51, issue.3, pp.250-251, 1996.

E. Lightburn, J. J. Morand, B. Graffin, S. Molinier, G. Raphenon et al., Pemphigoid and acquired hemophilia, Ann Dermatol Venereol, vol.128, issue.11, pp.1229-1260, 2001.

R. S. Patel, Acquired haemophilia heralded by bleeding into the oral mucosa in a patient with bullous pemphigoid, rheumatoid arthritis, and vitiligo, Postgrad Med J, vol.82, issue.963, pp.3-3, 2006.

G. Zhang, W. Zuo, C. Dai, Y. Xu, J. Shen et al., Characterization of an acquired factor VIII inhibitor and plasmapheresis therapy in a patient with bullous pemphigoid, Thromb Haemost, vol.96, issue.5, pp.692-696, 2006.

S. Gupta and A. Mahipal, A case of acquired hemophilia associated with bullous pemphigoid, Am J Hematol, vol.82, issue.6, p.502, 2007.
DOI : 10.1002/ajh.20890

A. Soria, E. Matichard, V. Descamps, and B. Crickx, Bullous pemphigoid and acquired hemophilia, Ann Dermatol Venereol, vol.134, issue.4, pp.353-359, 2007.

A. Ryman, T. Hubiche, J. Amiral, A. Taïeb, and V. Guerin, Acquired haemophilia A associated with transitory and severe factor V deficiency during bullous pemphigoid: first report, Thromb Haemost, vol.101, issue.3, pp.582-585, 2009.

A. Caudron, D. Chatelain, C. O. Lok, C. Roussel, B. Viseux et al., Favourable progression of acquired hemophilia-associated bullous pemphigoid, Eur J Dermatol, vol.19, issue.4, pp.383-387, 2009.

C. Chen, Y. Chen, J. Ho, and C. Wu, Bullous pemphigoid associated with acquired hemophilia, Dermatol Sin, vol.28, issue.4, pp.173-179, 2010.
DOI : 10.1016/s1027-8117(10)60038-9

URL : https://doi.org/10.1016/s1027-8117(10)60038-9

N. Kluger, R. Navarro, V. Pallure, and B. Guillot, Pemphigoïde bulleuse et hémophilie acquise
DOI : 10.1016/j.annder.2011.01.040

, Ann Dermatol Venereol, vol.138, issue.5, pp.422-425, 2011.

C. Nguyen, A Little Known but Potentially Life-threatening Association of Bullous Pemphigoid and Acquired Hemophilia: Case Report and Review of the Literature, J Dermatol Res Ther, issue.S6, p.1, 2012.

X. Zhang, J. Guo, X. Guo, and J. Pan, Successful treatment of acquired haemophilia in a patient with bullous pemphigoid with single-dosing regimen of rituximab, Haemophilia, vol.18, issue.5, pp.393-398, 2012.

N. Ammannagari, K. Laveaux, and S. Grethlein, Acquired Hemophilia in the Setting of Bullous Pemphigoid: A Case Report, J Hematol, vol.2, issue.2, pp.74-75, 2013.

S. Makita, T. Aoki, A. Watarai, A. Aida, T. Katayama et al., Acquired hemophilia associated with autoimmune bullous diseases: a report of two cases and a review of the literature, Intern Med Tokyo Jpn, vol.52, issue.7, pp.807-817, 2013.

M. I. Aljasser, C. Sladden, R. I. Crawford, and S. Au, Bullous pemphigoid associated with acquired hemophilia a: a rare association of autoimmune disease, J Cutan Med Surg, vol.18, issue.2, pp.123-129, 2014.

M. Tana, C. Tana, P. Amerio, G. Vitullo, P. Di-giosia et al., Severe non-traumatic bleeding, the answer is not in the blood, Intern Emerg Med, vol.10, issue.4, pp.461-465, 2015.

A. Y. Chan, D. Punwani, T. A. Kadlecek, M. J. Cowan, J. L. Olson et al., A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP

, J Exp Med, vol.213, issue.2, pp.155-65, 2016.

R. Prud'homme, S. Assikar, D. Audevard, and C. Bédane, Dermatoses bulleuses auto-immunes et hémophilie A acquise : 2 pathologies éloignées mais qui semblent se rapprocher par l'immunologie, Ann Dermatol Venereol, vol.143, issue.12, p.223, 2016.

Q. Binet, C. Lambert, L. Sacré, S. Eeckhoudt, and C. Hermans, Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature, Case Rep Hematol, vol.2017, pp.1-7

A. Pavlova, H. Zeitler, I. Scharrer, H. Brackmann, and J. Oldenburg, HLA genotype in patients with acquired haemophilia A, Haemophilia, vol.16, issue.102, pp.107-119, 2010.

J. J. Yunis, N. Mobini, E. J. Yunis, C. A. Alper, R. Deulofeut et al., Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid, Proc Natl Acad Sci, vol.91, issue.16, pp.7747-51, 1994.

L. Büdinger, L. Borradori, C. Yee, R. Eming, S. Ferencik et al., Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls, J Clin Invest, vol.102, issue.12, pp.2082-2091, 1998.

J. Kahle, A. Orlowski, D. Stichel, J. F. Healey, E. T. Parker et al., Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia A, Blood, vol.10, issue.6, pp.808-816, 2017.

X. Qiu, G. Zhang, R. Xiao, J. Zhang, Y. Zhou et al., Acquired hemophilia associated with bullous pemphigoid: a case report, Int J Clin Exp Pathol, vol.5, issue.1, pp.102-106, 2012.